These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9538252)

  • 1. Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.
    Kitadokoro K; Hagishita S; Sato T; Ohtani M; Miki K
    J Biochem; 1998 Apr; 123(4):619-23. PubMed ID: 9538252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.
    Chandra V; Jasti J; Kaur P; Betzel Ch; Srinivasan A; Singh TP
    J Mol Biol; 2002 Jul; 320(2):215-22. PubMed ID: 12079380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into metal ion binding in phospholipases A2: ultra high-resolution crystal structures of an acidic phospholipase A2 in the Ca2+ free and bound states.
    Murakami MT; Gabdoulkhakov A; Genov N; Cintra AC; Betzel C; Arni RK
    Biochimie; 2006 May; 88(5):543-9. PubMed ID: 16376474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.
    Singh N; Jabeen T; Pal A; Sharma S; Perbandt M; Betzel C; Singh TP
    Proteins; 2006 Jul; 64(1):89-100. PubMed ID: 16596639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol,
    Sekar K; Eswaramoorthy S; Jain MK; Sundaralingam M
    Biochemistry; 1997 Nov; 36(46):14186-91. PubMed ID: 9369492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
    Scott DL; White SP; Browning JL; Rosa JJ; Gelb MH; Sigler PB
    Science; 1991 Nov; 254(5034):1007-10. PubMed ID: 1948070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin induces its anti-inflammatory effects through its specific binding to phospholipase A2: crystal structure of the complex formed between phospholipase A2 and aspirin at 1.9 angstroms resolution.
    Singh RK; Ethayathulla AS; Jabeen T; Sharma S; Kaur P; Singh TP
    J Drug Target; 2005 Feb; 13(2):113-9. PubMed ID: 15823962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
    Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution refinement of orthorhombic bovine pancreatic phospholipase A2.
    Sekar K; Sundaralingam M
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):46-50. PubMed ID: 10089393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.
    Schevitz RW; Bach NJ; Carlson DG; Chirgadze NY; Clawson DK; Dillard RD; Draheim SE; Hartley LW; Jones ND; Mihelich ED
    Nat Struct Biol; 1995 Jun; 2(6):458-65. PubMed ID: 7664108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.
    Hansford KA; Reid RC; Clark CI; Tyndall JD; Whitehouse MW; Guthrie T; McGeary RP; Schafer K; Martin JL; Fairlie DP
    Chembiochem; 2003 Mar; 4(2-3):181-5. PubMed ID: 12616631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary X-ray diffraction studies of a new crystal form of human secretory type IIA phospholipase A2.
    Church WB; Lei PW; Ogg DJ; Scott KF
    Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1482-4. PubMed ID: 11053860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-dimensional 1H-NMR studies of phospholipase-A2-inhibitor complexes bound to a micellar lipid-water interface.
    Dekker N; Peters AR; Slotboom AJ; Boelens R; Kaptein R; Dijkman R; de Haas G
    Eur J Biochem; 1991 Aug; 199(3):601-7. PubMed ID: 1868846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A2 at 1.5 A resolution provides an insight into the catalytic mechanism.
    Edwards SH; Thompson D; Baker SF; Wood SP; Wilton DC
    Biochemistry; 2002 Dec; 41(52):15468-76. PubMed ID: 12501175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution.
    Jabeen T; Singh N; Singh RK; Sharma S; Somvanshi RK; Dey S; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2005 Dec; 61(Pt 12):1579-86. PubMed ID: 16301791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius.
    Jain MK; Yu BZ; Rogers JM; Smith AE; Boger ET; Ostrander RL; Rheingold AL
    Phytochemistry; 1995 Jun; 39(3):537-47. PubMed ID: 7576451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.